Node Status
Live
Node Status
Learning Objectives
Describe
- The various Anti TB Drugs that are in use in NTEP
- The various types of formulations (single drug and FDC and simple tablet, dispersible and inejctions)
Sub Nodes
- First line anti TB drugs
- Fixed Dose Combinations [FDC]s
- Second Line anti TB drugs
- List of Drugs that can be Used Safely or Avoided along with Bedaquiline
- Use of Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen in Special Situations
- Use of Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen in Pre-existing Liver Disease
- Eligibility Criteria for Longer Oral M/XDR-TB Regimen
- Treatment Extension in Isoniazid [H] Mono/Poly DR-TB Regimen
- Constituents of Patient-wise Boxes [PWB] for Isoniazid [H] Mono/Poly DR-TB Regimen​
- Guidelines for Issuing Bedaquiline and Delamanid to the Patient
- Role of the State Drug Store [SDS] in the Constitution of Patient-wise Boxes
- Newer Anti-TB Drugs
- Newer Anti-TB Drugs: Bedaquiline [Bdq]
- Newer Anti-TB Drugs: Delamanid [Dlm]
- Quality Assurance of Anti-TB Drugs
- Reconstitution of Bedaquiline [Bdq] Bottle
- Use of M/XDR-TB Regimen in Pre-existing liver disease
- Patient-wise Boxes [PWB]